Dr. Amit Dutt

Dr. Amit Dutt is a PhD cancer genomics scientist and Professor at the Department of Genetics, University of Delhi South Campus, and a Tata Innovation Fellow. He is best known for his research in integrated cancer genomics, precision oncology, next-generation sequencing, and cancer biomarker discovery. He is a recipient of the Shanti Swarup Bhatnagar Prize for Medical Sciences — India's highest science honour.

Dr. Amit Dutt is a PhD research scientist, not a treating clinical oncologist. He is profiled on CancerFax as a cancer genomics and precision oncology expert whose research contributes to molecular diagnostics, biomarker identification, and targeted therapy frameworks. Patients requiring clinical treatment should work with a qualified treating oncologist, who may draw on genomic research such as Dr. Dutt's for precision therapy guidance.

Dr. Dutt's laboratory has worked on lung cancer, breast cancer, oral and head and neck cancer, cervical cancer, gallbladder cancer, and other cancers prevalent in India. His research focuses on identifying somatic genetic alterations, oncogenic drivers, therapeutic vulnerabilities, and clinically relevant biomarkers across these cancer types.

Dr. Dutt is best known for cancer genomics research — particularly the characterisation and functional validation of somatic alterations in Indian cancer patient cohorts. He received the Shanti Swarup Bhatnagar Prize in 2017 for work translating genomic discoveries into clinical insights. He is also known for developing HPVDetector (an NGS-based HPV genome detection tool) and the TMC-SNPdb Indian germline variant database, which support cancer genome interpretation.

Modern cancer care increasingly relies on molecular profiling to guide targeted and precision therapy. Dr. Dutt's genomic research provides the foundational data underpinning decisions such as whether a patient's tumour carries an EGFR mutation suitable for TKI therapy, or whether a breast cancer is driven by hormonal resistance pathways. CancerFax can help patients and care teams understand how precision oncology and NGS testing may be relevant to their case.

A direct individual international consultation service for Dr. Dutt was not verified through public sources. International patients seeking oncology consultations at ACTREC, Tata Memorial Centre or its affiliated institutions may use the official ACTREC international patient services channel. CancerFax can support medical report preparation, case coordination, and referral to appropriate clinical teams at Tata Memorial Centre, subject to institutional availability.

Submit your medical reports and any existing molecular profiling results through CancerFax using the 'Send Your Reports' button. The CancerFax team will review the documents, prepare a structured case summary, and coordinate the next steps with the relevant clinical or research team, subject to institutional availability and case acceptance.